GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have completely changed the landscape of weight management. For the first time, many people are achieving significant, sustained weight loss without surgery, extreme dieting, or hours in the gym. But as more people reach their goal weight on these medications, a new and increasingly common concern has emerged: skin laxity.
If you’ve lost a substantial amount of weight on a GLP-1 medication and are now noticing looser, less firm skin, you’re experiencing something dermatologists and med spas across the country are seeing daily. The rapid pace of GLP-1-driven weight loss, while incredible for overall health, doesn’t always give the skin time to adjust. Fortunately, non-invasive treatments like Sofwave are emerging as one of the most effective ways to address this specific type of skin laxity.
Weight loss achieved through GLP-1 medications tends to happen faster and more consistently than weight loss through diet and exercise alone. This is part of what makes these medications so effective, but it also means the skin has less time to gradually adapt.
Skin firmness depends largely on two structural proteins: collagen and elastin. Collagen gives skin its strength, while elastin allows it to stretch and recoil. When weight is gained over time, the skin stretches to accommodate the added volume. When that weight is lost quickly, the skin’s ability to “snap back” depends on how much collagen and elastin reserve it has left, and rapid, large-volume weight loss puts a lot of pressure on that reserve.
A few factors make GLP-1 users particularly prone to skin laxity:
The most commonly affected areas include the face and neck (sometimes referred to as “Ozempic face”), upper arms, abdomen, and thighs.
For many patients, this is an unexpected and frustrating part of an otherwise positive journey. After months of discipline and often significant financial investment in these medications, discovering loose or crepey skin can feel like a setback. Clothing may not fit the way expected, and some people report feeling like their skin doesn’t match the healthier body underneath it. This is a completely valid concern, and it’s one that non-surgical treatments are increasingly designed to address.
Sofwave is an FDA-cleared ultrasound device that has become a popular option for patients dealing with skin laxity after GLP-1-related weight loss. Unlike treatments that simply address the skin’s surface, Sofwave uses a technology called SUPERB (Synchronous Ultrasound Parallel Beam) to deliver precise ultrasound energy to the mid-dermis, the layer of skin responsible for producing collagen.
Here’s how the process generally works:
Because the results come from the body’s own regenerative process rather than an immediate physical effect, improvements build gradually and tend to look natural rather than abrupt.
Sofwave is particularly appealing for people managing GLP-1-related skin laxity for a few reasons:
It’s worth noting that Sofwave is best suited for mild to moderate skin laxity. Patients with significant, hanging excess skin, particularly after very large amounts of weight loss, may find that surgical procedures offer more dramatic results. However, for the growing number of GLP-1 patients dealing with early-stage or moderate skin laxity, Sofwave offers a meaningful, non-surgical improvement.
One question we hear often is whether patients should wait until they’ve reached their final goal weight before starting skin-tightening treatment. In many cases, addressing skin laxity earlier, even while still in the process of losing weight, can be beneficial. Since Sofwave stimulates the body’s own collagen production over time, starting treatment sooner allows the skin to begin rebuilding structural support throughout the weight-loss process rather than only afterward. A consultation with an experienced provider can help determine the best timing based on your individual goals and progress.
Navigating the physical changes that come with GLP-1 weight loss can be complicated, and skin laxity is one of the most common yet least discussed side effects. At Skin 22 Concierge, we understand the unique needs of patients on GLP-1 medications and offer Sofwave treatments designed to help skin keep pace with your weight-loss results.
Our concierge-style approach means every consultation is personalized to your specific body, goals, and timeline, whether you’re just beginning your GLP-1 journey or have already reached your goal weight. We’ll walk you through what to expect, how many sessions may be recommended, and how Sofwave can fit into your overall plan.
If GLP-1-related skin laxity is affecting your confidence, you don’t have to figure it out alone. Contact Skin 22 Concierge today to schedule a consultation and learn whether Sofwave is the right solution for you.
Learn more or book your consultation at myskin22.com.
